Literature DB >> 3258891

The role of IL-5 in IgA B cell differentiation.

G R Harriman1, D Y Kunimoto, J F Elliott, V Paetkau, W Strober.   

Abstract

IL-5 enhances secretion of IgA by B cells. The stage of B cell differentiation at which IL-5 enhances IgA secretion and the mechanism by which it exerts this effect are unknown. We examined these issues by separating Peyer's patch (PP) B cells into membrane IgA (mIgA)-positive and mIgA-negative cells with panning or cell sorting. When LPS was used to activate these cells, mIgA-positive PP B cells were induced by IL-5 (either as crude T cell supernatant or rIL-5 to secrete large amounts of IgA. In contrast mIgA-negative PP B cells showed no significant amount of IgA secretion with IL-5. In addition, rIL-5 did not cause expression of mIgA by mIgM-bearing B cells. The mechanism involved in enhancement of IgA secretion was evaluated by utilizing an ELISPOT assay to quantitate IgA secreting cells. Both unsorted PP B cells and mIgA-positive PP B cells, when incubated with IL-5, showed an increase in the number of IgA-secreting cells that was proportional to the increase in total secreted IgA. However, LPS-activated PP mIgA-positive B cells, when incubated with rIL-5, showed no increase in proliferation, as measured by [3H]thymidine incorporation indicating that the increase in IgA-secreting cells after incubation with IL-5 occurred not as a result of proliferation but rather through promotion of terminal differentiation. Thus, IL-5 acts as a differentiation factor on B cells which have already undergone isotype switch to IgA B cells, promoting differentiation into IgA-secreting cells with resultant increased IgA secretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258891

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Purification of immunoglobulin production stimulation factor II alpha derived from Namalwa cells.

Authors:  T Sugahara; S Shirahata; K Yamada; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

Review 2.  Physiological enhancement of immunoglobulin production of hybridomas in serum-free media.

Authors:  H Murakami; K Yamada; S Shirahata; A Enomoto; S Kaminogawa
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

3.  Activation of cholera toxin-specific T cells in vitro.

Authors:  C O Elson; S Solomon
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

Review 4.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

5.  Host defense against cholera toxin is strongly CD4+ T cell dependent.

Authors:  E Hörnqvist; T J Goldschmidt; R Holmdahl; N Lycke
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells.

Authors:  Sun K Lee; Beom K Choi; Young H Kim; Woo J Kang; Kwang H Kim; Shimon Sakaguchi; Jae H Suh; Tae Y Kim; Byoung S Kwon
Journal:  Immunology       Date:  2006-12       Impact factor: 7.397

Review 7.  Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells.

Authors:  J Rodrigo Mora; Ulrich H von Andrian
Journal:  Semin Immunol       Date:  2008-09-18       Impact factor: 11.130

8.  Expression of IL-5 receptors on B cells: role in mucosal B cell responses.

Authors:  G R Harriman; K C Allison; W Strober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

9.  Role for protein kinase C activation in IgA B cell terminal differentiation.

Authors:  Y S Li; M T Dearden-Badet; J P Revillard
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

10.  Mechanism of up-regulation of immunoglobulin A production in the intestine of mice unresponsive to lipopolysaccharide.

Authors:  Masahiro Kaneko; Yoshiyuki Akiyama; Hiroaki Takimoto; Yoshio Kumazawa
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.